Safe and Effective Medicines for Children

Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act

AvInstitute of Medicine,Board on Health Sciences Policy

Häftad, Engelska, 2012

785 kr

Tillfälligt slut

Beskrivning

The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.

Produktinformation

Utforska kategorier

Innehållsförteckning

Hoppa över listan

Mer från samma författare

Scientific Communication and National Security

National Academy of Engineering, National Academy of Sciences, Policy and Global Affairs, Institute of Medicine, and Public Policy Committee on Science, Engineering, Panel on Scientific Communication and National Security

Häftad

704 kr

Bereavement

Institute of Medicine, Committee for the Study of Health Consequences of the Stress of Bereavement

Häftad

967 kr

Preventing Low Birthweight

Institute of Medicine, Division of Health Promotion and Disease Prevention, Committee to Study the Prevention of Low Birthweight

Häftad

690 kr

Preventing Low Birthweight

Institute of Medicine, Division of Health Promotion and Disease Prevention, Committee to Study the Prevention of Low Birthweight

Häftad

238 kr

Assessing Medical Technologies

Institute of Medicine, Division of Health Promotion and Disease Prevention, Division of Health Sciences Policy, Committee for Evaluating Medical Technologies in Clinical Use

Inbunden

1 068 kr

Hoppa över listan

Du kanske också är intresserad av

Rare Diseases and Orphan Products

Institute of Medicine, Board on Health Sciences Policy, Committee on Accelerating Rare Diseases Research and Orphan Product Development, Thomas F. Boat, Marilyn J. Field

Häftad

534 kr

Mental Disorders and Disabilities Among Low-Income Children

and Medicine National Academies of Sciences, Engineering, Institute of Medicine, and Families Board on Children, Youth, Board on the Health of Select Populations, Committee to Evaluate the Supplemental Security Income Disability Program for Children with Mental Disorders, Joel T. Wu, Thomas F. Boat

Häftad

1 024 kr

Future of Disability in America

Institute of Medicine, Board on Health Sciences Policy, Committee on Disability in America, Alan M. Jette, Marilyn J. Field

Inbunden

844 kr

Safe Medical Devices for Children

Institute of Medicine, Board on Health Sciences Policy, Committee on Postmarket Surveillance of Pediatric Medical Devices, Hugh Tilson, Marilyn J. Field, Marilyn J Field

Inbunden

1 060 kr

Research Training in Psychiatry Residency

Institute of Medicine, Board on Neuroscience and Behavioral Health, Committee on Incorporating Research into Psychiatry Residency Training, Thomas F. Boat, Kathleen M. Patchan, Michael T. Abrams

Häftad

679 kr

When Children Die

Institute of Medicine, Board on Health Sciences Policy, Committee on Palliative and End-of-Life Care for Children and Their Families, Richard E. Behrman, Marilyn J. Field

Inbunden

677 kr

Workshop on Disability in America

Institute of Medicine, Board on Health Sciences Policy, Committee on Disability in America: A New Look, Linda Martin, Alan M. Jette, Marilyn J. Field

Häftad

762 kr

Approaching Death

Institute of Medicine, Committee on Care at the End of Life, Christine K. Cassel, Marilyn J. Field

Häftad

1 443 kr